Efficacy of Paracetamol in Addition to Morphine to Improve Analgesia in the Emergency Department (ParaMoED)
Primary Purpose
Analgesia
Status
Completed
Phase
Phase 4
Locations
Switzerland
Study Type
Interventional
Intervention
Paracetamol
Placebo
Morphine
Sponsored by
About this trial
This is an interventional treatment trial for Analgesia focused on measuring Paracetamol, Morphine
Eligibility Criteria
Inclusion Criteria:
- Patient with pain with Pain-score is more or equal than four in a numeric rating scale from zero to ten (i.e. indication for a treatment with morphine)
- Age over 18
- Signed informed consent. In case, patient is not able to sign the informed consent due to pain, at least verbal consent has to be provided. After pain relief, written informed consent with data and time has to be obtained
Exclusion Criteria:
- Analgesia in the past last 6 hours prior to visit at the emergency department
- Current Analgesia with long-acting/extended-release drugs
- Current Analgesia with opioids
- Chronic pain syndrome
- Contraindication for either paracetamol or morphine
- Patient's refusal of paracetamol or morphine treatment
- Pregnancy or Breastfeeding
- GCS < 13
- SpO2 < 90% with a maximum of 4 L/Min O2
- Systolic Blood Pressure < 90 mmHg
- "Fast Track"/Notfallpraxis patients
Sites / Locations
- Kantonsspital St.Gallen
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Paracetamol
Placebo
Arm Description
Paracetamol 1 g (100 mL) IV + Morphine 0.1 mg/kg IV (repeatable in Doses of 0.05 mg/kg), 100 patients over 4 hours
Placebo (NaCl 0.9% 100 mL IV) + Morphine 0.1 mg/kg IV (repeatable in Doses of 0.05 mg/kg), 100 patients over 4 hours
Outcomes
Primary Outcome Measures
Assessment of the total dose of morphine till pain < 4 on the NRS (0-10) after the first infusion of paracetamol or placebo.
Secondary Outcome Measures
Assessment of time interval of pain < 4 on the NRS (after been achieved)
Total dose of morphine within the first 4 hours after the first infusion of paracetamol or Placebo.
Prevalence of morphine adverse reactions within the first 4 hours after infusion of paracetamol or placebo
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03843281
Brief Title
Efficacy of Paracetamol in Addition to Morphine to Improve Analgesia in the Emergency Department
Acronym
ParaMoED
Official Title
Efficacy of Paracetamol in Addition to Morphine to Improve Analgesia in the Emergency Department: a Multicenter, Randomized, Double-blind, Placebo-controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
October 2020
Overall Recruitment Status
Completed
Study Start Date
May 2, 2019 (Actual)
Primary Completion Date
October 15, 2020 (Actual)
Study Completion Date
October 15, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Bruno Minotti
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to test the additional effect of paracetamol in combination with morphine for analgesia, respectively to test/confirm an opioid sparing effect due to the additional use of Paracetamol, as well as the reduction of adverse drug reactions of morphine.
Detailed Description
Paracetamol (acetaminophen) is widely used around the world for mild to moderate pain in all age groups. Prescription at the emergency department is very common and some studies suggest the use in alternative of Morphine, at least in the renal colic.
Morphine has also a complex analgesic effect due to inhibition of µ Receptors in the central nervous system and in the dorsal horn of the spinal cord. Morphine (like other opioids) is accepted as a cornerstone of acute pain management in the emergency department. However, occurrence of adverse drug reactions is up to 25%, mainly nausea and drowsiness.
The use of paracetamol in addition to morphine showed in a meta-analysis in the post-operative setting an opioid sparing effect of 20% over the first postoperative 24 hours, but did not change the incidence of morphine-related adverse effects in the postoperative period. An additive effect was showed of the two medicaments in another Study measuring the median effective analgesic dose (ED50).
The purpose of this study is to test the additional effect of paracetamol in combination with morphine for analgesia, respectively to test/confirm an opioid sparing effect due to the additional use of Paracetamol, as well as the to reduction of adverse drug reactions of morphine.
The study is a multicenter, randomized, double-blind, placebo-controlled. We randomize patients with pain-score >=4 on a pain Scala of 0-10 Points (numeric rating scale) in two group, one with paracetamol, one with placebo to investigate the (additive) effect of paracetamol in combination with morphine. The treatment team and the patients will be blinded to the administration. The study design is outlined to confirm the result of previous studies who stated a 20% reduction of morphine doses when combined with paracetamol. Study duration for each patient would be 240 min.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Analgesia
Keywords
Paracetamol, Morphine
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
222 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Paracetamol
Arm Type
Experimental
Arm Description
Paracetamol 1 g (100 mL) IV + Morphine 0.1 mg/kg IV (repeatable in Doses of 0.05 mg/kg), 100 patients over 4 hours
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Placebo (NaCl 0.9% 100 mL IV) + Morphine 0.1 mg/kg IV (repeatable in Doses of 0.05 mg/kg), 100 patients over 4 hours
Intervention Type
Drug
Intervention Name(s)
Paracetamol
Other Intervention Name(s)
Paracetamol Sintetica
Intervention Description
s. above
Intervention Type
Drug
Intervention Name(s)
Placebo
Other Intervention Name(s)
NaCl 0.9%
Intervention Description
s. above
Intervention Type
Drug
Intervention Name(s)
Morphine
Other Intervention Name(s)
Morphine Sintetica
Intervention Description
s. above
Primary Outcome Measure Information:
Title
Assessment of the total dose of morphine till pain < 4 on the NRS (0-10) after the first infusion of paracetamol or placebo.
Time Frame
up to 4 hours
Secondary Outcome Measure Information:
Title
Assessment of time interval of pain < 4 on the NRS (after been achieved)
Time Frame
up to 4 hours
Title
Total dose of morphine within the first 4 hours after the first infusion of paracetamol or Placebo.
Time Frame
up to 4 hours
Title
Prevalence of morphine adverse reactions within the first 4 hours after infusion of paracetamol or placebo
Time Frame
up to 4 hours, respectively in case of serious adverse events up to recovery time of the patient
Other Pre-specified Outcome Measures:
Title
Maximal Dose of Morphine based on adverse events
Description
A maximal Dose of opioids has been defined in our daily practice and in several guidelines with a precise number (e.g. 20 mg/4 h). In this trial we will use instead a maximal Dose defined with clinical criteria (GCS < 13, SpO2 < 90% with 4 L/min O2, uncontrolled vomiting). Assessment intended as occurrence of adverse events of the application of a such algorithms will be outcome of interest (not a secondary outcome because absence of a control group)
Time Frame
up to 4 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient with pain with Pain-score is more or equal than four in a numeric rating scale from zero to ten (i.e. indication for a treatment with morphine)
Age over 18
Signed informed consent. In case, patient is not able to sign the informed consent due to pain, at least verbal consent has to be provided. After pain relief, written informed consent with data and time has to be obtained
Exclusion Criteria:
Analgesia in the past last 6 hours prior to visit at the emergency department
Current Analgesia with long-acting/extended-release drugs
Current Analgesia with opioids
Chronic pain syndrome
Contraindication for either paracetamol or morphine
Patient's refusal of paracetamol or morphine treatment
Pregnancy or Breastfeeding
GCS < 13
SpO2 < 90% with a maximum of 4 L/Min O2
Systolic Blood Pressure < 90 mmHg
"Fast Track"/Notfallpraxis patients
Facility Information:
Facility Name
Kantonsspital St.Gallen
City
Sankt Gallen
ZIP/Postal Code
9007
Country
Switzerland
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Efficacy of Paracetamol in Addition to Morphine to Improve Analgesia in the Emergency Department
We'll reach out to this number within 24 hrs